`

CureVac

Biotechnology Research

Specialities :
Mrna therapeutics
Cancer therapies
Prophylactic vaccines
Molecular therapies
Oncology

+2

revenue-icon Revenue
501M - 1B
funding-icon Total Funding
$250.0M
size-icon Size
501 - 1000

Frequently Asked Questions About CureVac

What does Curevac do?+

CureVac (Nasdaq: CVAC) is a pioneering multinational biotech company founded in 2000 to advance the field of messenger RNA (mRNA) technology for application in human medicine. In more than two decades of developing, optimizing, and manufacturing this versatile biological molecule for medical purposes, CureVac has introduced and refined key underlying technologies that were essential to the production of mRNA vaccines against COVID-19, and is currently laying the groundwork for application of mRNA in new therapeutic areas of major unmet need. CureVac is leveraging mRNA technology, combined with advanced omics and computational tools, to design and develop off-the-shelf and personalized cancer...

What are Curevac's specialties? +

Mrna therapeutics,cancer therapies,prophylactic vaccines,molecular therapies,oncology,research and development,and manufacturing

What is Curevac's industry? +

Curevac operates in the Biotechnology research industry.

What is Curevac's HQ phone number? +

Curevac's HQ phone number is +49711 615541

What is Curevac's revenue? +

Curevac's revenue is 501m - 1b

What is Curevac's company size? +

Curevac has 501 - 1000 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.